Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone hydrochloride and metformin hydrochloride tablets for polycystic ovary syndrome
ChiCTR-OPC-17011930Phase 4Completed
- Sponsor
- Changhai Hospital
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pioglitazone and metformin in polycystic ovary syndrome (PCOS), sponsored by Changhai Hospital. Primary endpoints: insulin resistance, high testosterone and 1 more. Started Sep 2017; status: completed.
02
Drugs
pioglitazonemetformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-OPC-17011930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17011930.